On October 22, 2020, Boston-based Atea Pharmaceuticals, Inc. (“Atea”) announced an agreement with Roche for the exclusive rights to research,
Continue Reading Atea Pharmaceuticals Collaborates with Roche on Oral COVID-19 Therapeutic
Ryder Launches $50M Venture Fund for Supply Chain Startups
This week, Ryder System, Inc. (NYSE: R), announced a new corporate venture capital fund called RyderVentures.
The fund seeks to
Continue Reading Ryder Launches $50M Venture Fund for Supply Chain Startups
Eli Lilly to Buy Disarm Therapeutics for $135M Plus Potentially $1B+
Pharmaceutical giant Eli Lilly and Company will purchase four-year-old Disarm Therapeutics, a Cambridge-based biotechnology company, for $135 million up
Continue Reading Eli Lilly to Buy Disarm Therapeutics for $135M Plus Potentially $1B+
University of Cambridge Develops Virtual Reality Software to Help Explore Cells
Researchers at the University of Cambridge have developed software that produces super-resolution virtual, 3D images of cells contained in actual
Continue Reading University of Cambridge Develops Virtual Reality Software to Help Explore Cells
Moderna Reportedly Won’t Enforce its COVID-19 Vaccine Patents
Boston-based Moderna has announced that it will not enforce its patent rights related to its experimental vaccine for COVID-19, because
Continue Reading Moderna Reportedly Won’t Enforce its COVID-19 Vaccine Patents
Scribe Enters CRISPR-Based Collaboration with Biogen
On October 7, 2020, Scribe Therapeutics announced a collaboration with Biogen, to collaborate on CRISPR-based medicines for treating neurological
Continue Reading Scribe Enters CRISPR-Based Collaboration with Biogen
Aledia, French microLED Startup, Announces €80M First Tranche Close on €120M Round
French microLED display startup Aledia announced it closed an €80M first tranche of its €120M D-round financing. The company will
Continue Reading Aledia, French microLED Startup, Announces €80M First Tranche Close on €120M Round
A2 Biotherapeutics Closes $70+M Series B Round to Fund Cancer-Fighting Tmod Platform
Cambridge Startup Walden Biosciences Launches With $50M Raise
Cambridge startup biotechnology company Walden Biosciences announced its launch today with a $51 million Series A financing led by UCB
Continue Reading Cambridge Startup Walden Biosciences Launches With $50M Raise